Assessment of yellow fever epidemic risk: An original multi-criteria modeling approach

PLoS Neglected Tropical Diseases

Volumn 3, Issue 7, 2009, Pages

  Briand, Sylvie ^a   Beresniak, Ariel ^b   Nguyen, Tim ^a   Yonli, Tajoua ^c   Duru, Gerard ^d   Kambire, Chantal ^a   Perea, William ^a   Allarangar, Yokouide ^e   Avokey, Fenella ^e   Berthe, Adama ^e   Gbedonou, Placide ^e   Yactayo, Sergio ^e  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b et Institut de recherche et documentation en économie de la santé   (France)

^c Institut Bioforce Développement Afrique   (Burkina Faso)

^d UNIVERSITÉ LYON 1   (France)

^e Country Office ^*

Author keywords

[No Author keywords available]

Indexed keywords

YELLOW FEVER VACCINE;

ARTICLE; BURKINA FASO; ENVIRONMENTAL EXPOSURE; EPIDEMIC; HUMAN; INFECTION SENSITIVITY; INFORMATION PROCESSING; MEDICAL DECISION MAKING; POPULATION MIGRATION; PUBLIC HEALTH SERVICE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; VACCINATION; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS; METHODOLOGY;

BURKINA FASO; HUMANS; RISK ASSESSMENT; RISK FACTORS; YELLOW FEVER;

EID: 70449560397     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000483     Document Type: Article

References (59)

1. Shrewsbury JFD (1949) The Yellow Plague. J Hist Med Allied Sci IV: 5-47.
2. Robertson SE, Hull BP, Tomori O, Bele O, LeDuc JW, et al. (1996) Yellow fever: a decade of reemergence. JAMA 276: 1157-1162.
3. Wright FM (2001) The 1878 yellow fever epidemic in Memphis. J Miss State Med Assoc 42: 9-13.
4. Unknown (2001) The Detachment Hospital Corps, Columbia Barracks, Cuba 1900. Mil Med 166: 67.
5. Bruesch SR (1952) The disasters and epidemics of a river town: Memphis, Tennessee 1819-1879. Bull Med Libr Assoc 40: 288-305.
6. Maglen K (2002) The first line of defence: British quarantine and the Port Sanitary Authorities in the nineteenth century. Soc Hist Med 15: 413-428.
7. Leonard J (1981) The ghost of Yellow Jack. Harv Mag 83: 20-27.
8. Agramonte A (2001) The inside history of a great medical discovery. 1915. Mil Med 166: 68-78.
9. Trapido H, Galindo P (1955) The investigation of a sylvan yellow fever epizootic on the north coast of Honduras, 1954. Am J Trop Med Hyg 4: 665-674.
10. Sessa R, Palagiano C, Scifoni MG, di PM, Del PM (1999) The major epidemic infections: a gift from the Old World to the New? Panminerva Med 41: 78-84.
11. Ellis JH (1977) The New Orleans yellow fever epidemic in 1878: a note on the affective history of societies and communities. Clio Med 12: 189-216.
12. Foster KR, Jenkins MF, Toogood AC (1998) The Philadelphia yellow fever epidemic of 1793. Sci Am 279: 88-93.
13. Carrigan JA (1967) The yellow fever panic of 1897 in Louisiana. La Stud 6: 7-25.
14. Rogers DJ, Wilson AJ, Hay SI, Graham AJ (2006) The global distribution of yellow Fever and dengue. Adv Parasitol 62: 181-220.
15. Toovey S (2006) Travelling to Africa: health risks reviewed. Travel Med Infect Dis 4: 147-158.
16. Jong EC (1999) Travel immunizations. Med Clin North Am 83: 903-22, vi.
17. Lo RV III, Gluckman SJ (2004) Travel immunizations. Am Fam Physician 70: 89-99.
18. Arya SC (2002) Travel and yellow fever vaccine. J Travel Med 9: 334.
19. Shafer RT, Correia J, Patel V, Keystone JS (1996) Travel advice from embassies. Lancet 348: 757-758.
20. Wilson ME (2001) Travel-related vaccines. Infect Dis Clin North Am 15: 231-251.
21. Monath TP (2006) Yellow fever as an endemic/epidemic disease and priorities for vaccination. Bull Soc Pathol Exot 99: 341-347.
22. Poland JD, Calisher CH, Monath TP, Downs WG, Murphy K (1981) Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ 59: 895-900.
23. Cetron MS, Marfin AA, Julian KG, Gubler DJ, Sharp DJ, et al. (2002) Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep 51: 1-11.
24. WHO (2003) Yellow fever vaccine. WHO position paper. Wkly Epidemiol Rec 78: 349-359.
25. Gillett JD (1969) Yellow fever in East Africa today. East Afr Med J 46: 22-25.
26. Vainio J, Cutts F (1998) Yellow fever. Geneva: WHO.
27. WHO (2001) Yellow fever. Geneva.
28. Collomb H, Dumas M, Giordano C (1966) [Postvaccinal encephalitis (yellow fever vaccination); neuro-radiological study]. Bull Soc Med Afr Noire Lang Fr 11: 587-590.
29. Mar ID, Niang I, Guicheney A, Berne C, Collomb H, et al. (1967) [Encephalitis following anti-yellow fever vaccination (from 248 cases observed at Dakar in 1965)]. Ann Pediatr (Paris) 14: 181-191.
30. WHO (1984) Yellow fever in 1983. Wkly Epidemiol Rec 43: 329-335
31. Bres P, Causse G, Robin Y, Cornet M, Oudart JL (1966) [The epidemic of yellow fever in 1965 in Senegal]. Med Trop (Mars ) 26: Suppl-38.
32. Rey M, Robin Y, Camain R, Diop MI, Oudart JL, et al. (1966) [A focus of yellow fever in a rural environment]. Bull Soc Med Afr Noire Lang Fr 11: 541-549.
33. Wone I, Cornet M, Ly C, Lariviere M, Michel R, et al. (1966) [Yellow fever: general study of the epidemic in Senegal in 1965]. Bull Soc Med Afr Noire Lang Fr 11: 500-511.
34. Cornet M, Robin Y, Hannoun C, Corniou B, Bres P, et al. (1968) [An epidemic of yellow fever in Senegal in 1965. Epidemiological studies]. Bull World Health Organ 39: 845-858.
35. Monath TP (1999) Facing up to re-emergence of urban yellow fever. Lancet 353: 1541.
36. WHO (2005) The yellow fever situation in Africa and South America in 2004. Wkly Epidemiol Rec 80: 250-256.
37. WHO (2006) Yellow fever situation in Africa and South America, 2005. Wkly Epidemiol Rec 81: 317-324.
38. Tomori O (1999) Impact of yellow fever on the developing world. Adv Virus Res 53: 5-34.
39. Tomori O (2002) Yellow fever in Africa: public health impact and prospects for control in the 21st century. Biomedica 22: 178-210.
40. Tomori O (2004) Yellow fever: the recurring plague. Crit Rev Clin Lab Sci 41: 391-427.
41. WHO (2005) Progress in the control of yellow fever in Africa. Wkly Epidemiol Rec 80: 50-55.
42. Baltussen R, Niessen L (2006) Priority setting of health interventions: the need for multi-criteria decision analysis. Cost Eff Resour Alloc 4: 14. (Pubitemid 44377737)
43. Cardona OD (2003) The need for Rethinking the Concepts of Vulnerability and Risk from a Holistic Perspective: A Necessary Review and Criticism of Effective Risk Assessment. In: Bankoff G, Frerks D, Hillhorst D, eds (2003) Mapping Vulnerability: Disasters, Development and People. London: Earthscan Publishers.
44. Sutherst RW (2004) Global change and human vulnerability to vector-borne diseases. Clin Microbiol Rev 17: 136-173. (Pubitemid 38124454)
45. Monath TP, Nasidi A (1993) Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria. Am J Trop Med Hyg 48: 274-299.
46. Monath TP (2001) Yellow fever: an update. Lancet Infect Dis 1: 11-20.
47. Monath TP (1991) Yellow fever: Victor, Victoria? Conqueror, conquest? Epidemics and research in the last forty years and prospects for the future. Am J Trop Med Hyg 45: 1-43.
48. Benzecri JP (1992) Correspondance analyses. CRC Press 688.
49. Beresniak A, Duru G (1991) Economie de la santé. Coll. des abrégés de médecine - Edition MASSON.
50. Bouchet C, Hacene K, Martin PM, Becette V, Tubiana-Hulin M, et al. (1999) Dissemination risk index based on plasminogen activator system components in primary breast cancer. J Clin Oncol 17: 3048-3057. (Pubitemid 29470632)
51. Caroll JD, Green PE, Schaffer CM (1986) Interpoint Distance Comparisons in Correspondence Analysis. Journal of Marketing Research 23: 271-280.
52. Cortinovis I, Vella V, Ndiku J (1993) Construction of a socio-economic index to facilitate analysis of health data in developing countries. Soc Sci Med 36: 1087-1097. (Pubitemid 23103110)
53. Guinot C, Latreille J, Malvy D, Preziosi P, Galan P, et al. (2001) Use of multiple correspondence analysis and cluster analysis to study dietary behaviour: food consumption questionnaire in the SU.VI.MAX. cohort. Eur J Epidemiol 17: 505-516. (Pubitemid 34252676)
54. Tenehaus M, Young F-W (1985) An analysis and synthesis of multiple correspondence analysis, optimal scaling, dual scaling, homogeneity analysis, and other methods for quantifying categorial multivariate data. Psychometrika 50: 91-119.
55. Abdi H, Valentin D (2007) Multiple Correspondence Analysis. In: Salkind N, ed (2007) Encyclopedia of Measurements and Statistics. Sage.
56. Fellenberg K, Hauser NC, Brors B, Neutzner A, Hoheisel JD, et al. (2001) Correspondence analysis applied to microarray data. Proc Natl Acad Sci U S A 98: 10781-10786. (Pubitemid 32878697)
57. Greenacre M (1992) Correspondence analysis in medical research. Stat Methods Med Res 1: 97-117.
58. Monath TP, Nasidi A (1993) Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria. Am J Trop Med Hyg 48: 274-299.
59. Guba EG, Lincoln YS (1989) Fourth Generation Evaluation. Newbury park: SAGE publications.